References
- Falk R H, Comenzo R L, Skinner M. The systemic amyloidoses. New Engl J Med 1997; 337: 898–909
- Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057–1062
- Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003; 10: 160–184
- Coelho T, Sousa A, Lourenco E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994; 31: 293–299
- Suhr O B, Svendsen I H, Andersson R, Danielsson A, Holmgren G, Ranlov P J. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 2003; 254: 225–235
- Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
- Plante-Bordeneuve V, Lalu T, Misrahi M, Reilly M M, Adams D, Lacroix C, Said G. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 1998; 51: 708–714
- Jacobson D R, Pastore R D, Yaghoubian R, Kane I, Gallo G, Buck F S, Buxbaum J N. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. New Engl J Med 1997; 336: 466–473
- Ikeda S. Cardiac amyloidosis. Heterogeneous pathogenic backgrounds. Intern Med 2004; 43: 1107–1114
- Falk H R. Diagnosis and management of the cardiac amyloidosis. Circulation 2005; 112: 2047–2060
- Suhr O B, Herlenius G, Friman S, Ericzon B G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263–276
- Stangou A J, Hawkins P N, Heaton N D, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys M B, Williams R. Progressive cardiac amyloidosis following liver transplantation for amyloid polyneuropathy. Transplantation 1998; 66: 229–233
- Sharma P, Perri R E, Sirven J E, Zeldenrust S R, Brandhagen D J, Rosen C B, Douglas D D, Mulligan D C, Rakela J, Wiesner R H, Balan V. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transplant 2003; 9: 1273–1280
- Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid 2003; 10: 229–239
- Ferlini A, Fini S, Salvi F, Patrosso M C, Vezzoni P, Forabosco A. Molecular strategies in genetic diagnosis of transthyretin-related hereditary amyloidosis. FASEB J 1992; 6: 2864–2866
- Coutinho P, Martins da Silva A, Lopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid neuropathy. Amyloid and amyloidosis, G G Glenner, P P Costa, A F Freitas. Excerpta Medica, Amsterdam 1980; 88–98
- Devereux R B, Alonso D R, Lutas E M, Gottlieb G J, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458
- Garcia M J, Thomas J D, Klein A L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865–875
- Trikas A, Rallidis L, Hawkins P, Oakley C M, Nihoyannopoulos P. Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis. Am J Cardiol 1999; 84: 1049–1054
- Patrosso M C, Salvi F, De Grandis D, Vezzoni P, Jacobson D R, Ferlini A. Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis. Am J Med Genet 1998; 77: 135–138
- Ferlini A, Salvi F, Uncini A, el-Chami J, Winter P, Altland K, Repetto M, Littardi M, Campoleoni A, Vezzoni P, Patrosso M C. Homozygosity and heterozygosity for the transthyretin Leu64 mutation: clinical, biochemical and molecular findings. Clin Genet 1996; 49: 10–14
- Ferlini A, Patrosso M C, Repetto M, Frattini A, Villa A, Fini S, Salvi F, Vezzoni P, Forabosco A. A new mutation (TTR Ala-47) in the transthyretin gene associated with hereditary amyloidosis. Hum Mutat 1994; 4: 61–64
- Salvi F, Martinelli P, Meleti S, Ferlini A. Motor neuropathy as the unusual clinical presentation of TTR related hereditary amyloidosis (Ile68Leu). Proceedings of the 4th International Symposium on FAP and Other TTR related Disorders, UmeaSweden, June, 1999
- Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Cescon M, Grazi G L, Salvi F, Magelli C, Grigioni F, Arpesella G, Martinelli G, Cavallari A. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant Proc 2004; 36: 645–647
- Salvi F, Scaglione C, Michelucci R, Linke R P, Obici L, Ravani A, Rimessi P, Ferlini A, Meletti S, Cavallaro T, Tassinari C A, Martinelli P. Atypical familial motor neuropathy in patients with mutant TTR Ile68Leu. Amyloid 2003; 10: 185–189
- Almeida M R, Ferlini A, Forabosco A, Gawinowicz M, Costa P P, Salvi F, Plasmati R, Tassinari C A, Altland K, Saraiva M J. Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat 1992; 1: 211–215
- Perugini E, Rapezzi C, Reggiani L, Poole-Wilson P, Branzi A, Henein M Y. Comparison of ventricular long-axis function in patients with cardiac amyloidosis versus idiopathic restrictive cardiomyopathy. Am J Cardiology 2005; 95: 146–149
- Ng B, Connors L H, Davidoff R, Skinner M, Falk R H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005; 175: 1425–1429
- Stangou A J, Hawkins P N, Heaton N D, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys M B, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. Transplantation 1998; 66: 229–233